发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 321 |
| Canada | 44 |
| Netherlands | 18 |
| England | 12 |
| Japan | 12 |
| Australia | 8 |
| India | 8 |
| Switzerland | 6 |
| CHINA MAINLAND | 5 |
| France | 5 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 51 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 38 |
| HARVARD UNIVERSITY | 36 |
| UNIVERSITY OF PENNSYLVANIA | 26 |
| JOHNS HOPKINS UNIVERSITY | 23 |
| MAYO CLINIC | 23 |
| STATE UNIVERSITY SYSTEM OF FLORIDA | 22 |
| WASHINGTON UNIVERSITY (WUSTL) | 22 |
| DUKE UNIVERSITY | 21 |
| UNIVERSITY OF TORONTO | 21 |
文章引用情况
1
An interactive contouring module improves engagement and interest in radiation oncology among preclinical medical students: Results of a randomized trial2
Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences3
The impact of imaging modality (CT vs MRI) and patient position (supine vs prone) on tangential whole breast radiation therapy planning4
Five-field IMRT class solutions and dosimetric planning guidelines for implementing accelerated partial breast irradiation5
A Burnout Reduction and Wellness Strategy: Personal Financial Health for the Medical Trainee and Early Career Radiation Oncologist6
Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis7
Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model8
Three-Dimensional Bioabsorbable Tissue Marker Placement is Associated with Decreased Tumor Bed Volume Among Patients Receiving Radiation Therapy for Breast Cancer9
Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery10
Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network